Evogene and ICL Subsidiary Collaborate

Evogene and ICL Innovation, a subsidiary of ICL, said Tuesday they have entered a multi-year research and development collaboration for the discovery of novel crop enhancers for the improvement of nutrient use efficiency in selected crops.EVGN shares were down 2.4% and ICL shares were down 1.7% in recent trading.

Under the terms of the agreement, Evogene will use its computational discovery platform to identify the potential of certain compounds to improve nutrient use efficiency. Successful candidates identified from the collaboration may be integrated into ICL’s product pipeline for further development and formulation.

Expected commercialization of products derived from the joint efforts may occur as early as five years from initiation of the research and development activities.

Leave a Comment